Delivery Order SPE2DB22D2108-SPE2DB25FU5PF
Award Date 8/22/25
Potential Completion Date 8/25/25
Potential Value $24K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $32,117.15 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 (60-count units), a combination respiratory medication used to treat chronic obstructive pulmonary disease. This firm fixed-price delivery order, awarded on August 7, 2025, was issued without a set-aside designation and is scheduled for completion by August 8, 2025. AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania serves as the place...
- The Defense Logistics Agency awarded a delivery order valued at $27,169.72 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25, a combination respiratory medication, with an ultimate completion date of August 13, 2025. This competitively awarded, firm fixed-price delivery order was issued under a non-set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen, a major pharmaceutical distributor, serves as a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,930.97 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 60S, a pharmaceutical product for respiratory treatment. The contract, awarded on July 29, 2025, with an ultimate completion date of July 30, 2025, operates under firm fixed price terms with no set-aside designation. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania served as the place of performance for this competitively awarded...
- The Defense Logistics Agency awarded a delivery order valued at $51,571.36 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 (60-count units), a combination inhalation medication used in respiratory disease management. This firm fixed price delivery order, issued on August 15, 2025, with an ultimate completion date of August 18, 2025, represents a non-set-aside competitive award. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $11,167.61 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25, a combination respiratory medication, with an ultimate completion date of August 21, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $16,422.72 for TRELEGY ELLIPTA 200-62.5-25 60S, a combination respiratory medication used to treat chronic obstructive pulmonary disease. The contract was awarded on July 22, 2025, with an ultimate completion date of July 23, 2025, and utilizes firm fixed pricing with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $25,630.25 to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25 inhalers (60-count units) on August 7, 2025, with completion scheduled for August 8, 2025. This non-competitive, firm fixed-price delivery order was placed against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026. The product...
- The Defense Logistics Agency awarded a delivery order valued at $7,298.96 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25, a combination respiratory medication containing fluticasone, umeclidinium, and vilanterol used to treat chronic obstructive pulmonary disease. The order, placed on August 18, 2025, with an ultimate completion date of August 19, 2025, was competitively awarded without set-aside designation under firm fixed-price terms. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order valued at $13,390.69 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25 60S, a combination pharmaceutical product used in respiratory disease treatment. This firm fixed-price, non-set-aside delivery order was awarded on August 12, 2025, with an ultimate completion date of August 13, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child delivery order,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,435.33 to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25 60S, a combination inhalation medication used to treat chronic obstructive pulmonary disease. This firm fixed-price delivery order, awarded on August 14, 2025, with an ultimate completion date of August 15, 2025, represents a non-competitive set-aside procurement executed through AmerisourceBergen's existing contract vehicle with the DLA. The place of...